Hyperfine, Inc. the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—announced a collaboration with the Medical University of South Carolina to assess the brains of astronauts before and after embarking on the Polaris Dawn mission.
Thermo Fisher Scientific, the world leader serving science, announced the latest recipients of the Oncomine Clinical Research Grant, designed to support emerging research on molecular profiling in oncology and to help democratize the future of precision medicine.
ThinkLite Air, a pioneer in indoor air quality (IAQ) solutions, proudly announces its collaboration with Medxcel, a subsidiary of Ascension and most recently, Prime Healthcare, to enhance patient safety at a Texas children's hospital.
StatLab Medical Products a leading global developer and manufacturer of medical diagnostic supplies and equipment, announced that it has reached an agreement to acquire Diapath S.p.A. (“Diapath”), a prominent Italian manufacturer of histology and cytology products and equipment.
AISAP, a medical technology company developing AI-powered Point-of-Care Assisted Diagnosis (POCAD™) solutions to transform medical ultrasound, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its first-of-a-kind, AI-powered AISAP CARDIO point-of-care ultrasound (POCUS) software platform.
Alafia Ai, Inc. announces the general availability of AIVAS, an all-in-one interactive high-performance personal supercomputer designed to revolutionize the development and deployment of critical artificial intelligence (AI) software applications in healthcare.
LensCrafters, part of EssilorLuxottica and one of the largest optical retail brands in North America, announced the launch of LensCrafters Adaptive™ Progressive Lenses, the retailer's most advanced, tailored and highly personalized progressive lenses delivering an optimal visual experience.
THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, announced that its TMINI® Miniature Robotic System (TMINI 1.1) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Ceribell, Inc., a commercial-stage medical technology company focused on transforming the detection and management of patients with serious neurological conditions, announced the publication of results from a new multi-center retrospective study of patient outcomes following use of the Ceribell system compared to conventional electroencephalography ("EEG").
A patient in Cincinnati has become the first in the United States to receive an innovative system that enables remote monitoring of his heart and congestion status, as well as self-adjustment of diuretics.